<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4889">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04527835</url>
  </required_header>
  <id_info>
    <org_study_id>Viral myocarditis</org_study_id>
    <nct_id>NCT04527835</nct_id>
  </id_info>
  <brief_title>Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis</brief_title>
  <official_title>Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Presentation, Clinical Course and Patterns of Myocardial Damage due to Viral Myocarditis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Determine the pattern of myocarditis in hospitalized patients with acute HF within the&#xD;
           last 3 months.&#xD;
&#xD;
        2. Determine the pattern of broad spectrum cardiotropic viruses in patients with acute HF&#xD;
           within the last 3 months. These viruses like enteroviruses, adenoviruses and parvo B19&#xD;
           virus, HBV, HCV and Covid 19 virus due to its increased prevelance nowadays.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the pattern of myocarditis in hospitalized patients with acute HF within the last 3 months</measure>
    <time_frame>6 months</time_frame>
    <description>All patients admitted with symptoms , signs and echocardiographic finding suggesting myocarditis within 3 months from start of the symptoms. as acute heart failure, arrhythmias, typical chest pain with ST segment deviation in ECG . dilated cardiomyopathy associated with normal Coronary Angiography, history of upper respiratory tract infection within the last 3 months. All will be investigated for determine the pattern of viral myocarditis in those patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>determination of the caustive organism</measure>
    <time_frame>6 months</time_frame>
    <description>1. Determine the pattern of broad spectrum cardiotropic viruses in patients with acute HF within the last 3 months. These viruses like enteroviruses, adenoviruses and parvo B19 virus, HBV, HCV and Covid 19 virus due to its increased prevelance nowadays.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Viral Myocarditis</condition>
  <arm_group>
    <arm_group_label>patients suspected for viral myocarditis</arm_group_label>
    <description>All patients admitted with unexplained heart failure in the last 3 months will be investigated for viral myocarditis by the use of 12 lead ECG, echocardiography, Cardiac MRI , coronary angiography, Endomyocardial biopsy ( optional ), serological tests including ELIZA,Extraction of nucleic acid, Determination of viral genome by using PCR., Quantitative real-time PCR to assess viral load, Immunohistochemistry analysis of EMB.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB.</intervention_name>
    <description>ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB.</description>
    <arm_group_label>patients suspected for viral myocarditis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients complained of symptoms of moderate to severe heart disease including atypical&#xD;
        chest pain, fatigue, reduced physical capacity, recently occurring cardiac arrhythmia,&#xD;
        and/or dyspnea on exertion suggesting myocardial inflammation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: All patients admitted with symptoms , signs and echocardiographic&#xD;
        finding suggesting myocarditis within 3 months from start of the symptoms. as acute heart&#xD;
        failure, arrhythmias, typical chest pain with ST segment deviation in ECG . dilated&#xD;
        cardiomyopathy associated with normal Coronary Angiography, history of upper respiratory&#xD;
        tract infection within the last 3 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with significant coronary artery disease.&#xD;
&#xD;
          2. Patient with family history suggesting familial DCMP&#xD;
&#xD;
          3. Critically ill patients.&#xD;
&#xD;
          4. Patients who refuse to do coronary angiography . .&#xD;
&#xD;
          5. Patients with severe valvular heart disease.&#xD;
&#xD;
          6. Pregnant women&#xD;
&#xD;
          7. Patients with raised renal chemistry.&#xD;
&#xD;
          8. Echocardiographic finding showing LVEDD more than 6.5cm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayman khairy, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed El Mokhtar, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shery Asaad, Resident</last_name>
    <phone>01270992244</phone>
    <email>drshosho31@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amr yousif, professor</last_name>
    <phone>01027355511</phone>
    <email>amryoussef111@aun.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shery Refaat Asaad</name>
      <address>
        <city>Assiut</city>
        <zip>23123</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shery Asaad, resident</last_name>
      <phone>01270992244</phone>
      <email>drshosho31'@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Ayman khairy, assistant professor</last_name>
      <phone>01094438055</phone>
      <email>Ayman.hassan@aun.edu.eg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 23, 2020</study_first_submitted>
  <study_first_submitted_qc>August 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Shery Refaat Asaad</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

